Arindam Bose

Dr. Arindam Bose is currently an advisor to Signet and Vice President (part-time) of Process Development at Akero Therapeutics, responsible for drug substance process development and manufacturing for its lead asset.
He is also an Independent Director of Dyadic International (Nasdaq: DYAI), a global biotechnology company.
Prior to that, he spent over 30 years at Pfizer where he last served as Vice President of External Affairs & Biosimilars Strategy in the Biotherapeutics Pharmaceutical Sciences division.
His numerous technical and leadership positions at Pfizer encompassed process development, clinical supply/commercial manufacturing, corporate biotechnology strategy and lobbying for science-based regulations for biologics and vaccines.
Arin has served as the Chair of the Biologics and Biotechnology Leadership Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA), the chief advocacy arm of the US pharmaceutical industry.
His outstanding accomplishments have been recognized by his election as “Fellow” of 3 leading professional organizations: American Chemical Society, American Institute of Chemical Engineers and American Institute for Medical and Biological Engineering; as well as by his election to Membership in the prestigious US National Academy of Engineering.
Arin holds a PhD in Chemical Engineering from Purdue University, an MS in Chemical Engineering from the University of Michigan, Ann Arbor, and a BTech in Chemical Engineering from the Indian Institute of Technology, Kanpur.